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Sepsis in the pediatric intensive care unit (PICU) has always been challenging to the treating physician. Early institution of an appropriate antimicrobial regimen in infected patients 
is associated with a better outcome, and hence, early diagnosis is 
vital. Clinical examination is not always reliable in distinguishing 
between patients with bacterial sepsis and systemic inflammatory 
response syndrome (SIRS). This along with the lack of specific 
early markers of infection may be responsible for withholding or 
delaying antimicrobial treatment in critically ill patients.
There is a need for an effective and accurate biochemical 
marker to support or exclude the diagnosis of infection. 
Procalcitonin (PCT) has emerged as a more reliable marker to 
differentiate SIRS from systemic inflammation than C-reactive 
protein (CRP), interleukin-1 (IL-1) in adult studies [1-4]. PCT 
has also been a more reliable marker in early neonatal sepsis 
within 12 h of life than either CRP or IL-6 [5]. However, 
conflicting data exists about the role of PCT in the diagnosis 
of sepsis in children. Hence, this study was undertaken to study 
the serum PCT levels in children with the diagnosis of sepsis 
and to assess its correlation with the severity of the disease.
METHODOLOGY
This was a prospective, observational study, enrolling children 
aged 1 month to 15 years, admitted to M. S. Ramaiah Memorial 
Hospital with suspicion of sepsis over 1 year. After obtaining 
approval from the Hospital Ethics Committee and informed 
consent from parents, all consecutive patients admitted to 
hospital with suspicion of sepsis were enrolled and observed 
till discharge, transfer, or death.
The sample size was calculated for 95% confidence interval, 
80% power of the study, and came to 48 cases. Children 
with chronic systemic/inflammatory disease, degenerative 
neurologic disease, primary/acquired immune deficiency, on 
steroids and children who had an illness for more than 48 h 
and on antibiotics or recently vaccinated, children who had 
trauma/burns were excluded. On admission, detailed history 
and clinical examination were done, and the children were 
assigned to the various groups of the sepsis classification, viz., 
SIRS, sepsis, severe sepsis, and septic shock on admission [6]. 
SIRS, sepsis, and septic shock were defined according to the 
criteria established by the Consensus on International Sepsis 
Definitions Conference, 2001 [6].
The initial diagnosis on admission was used to assign patients 
to each of the study groups. Complete blood counts, blood 
culture, serum CRP, and serum PCT were done on admission 
for all cases. Other investigations, such as arterial blood 
gases, urine microscopy, specimen culture, serum electrolytes, 
renal function tests, liver function tests, coagulation profile, 
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and chest X-ray, were done as per requirement in each case. 
Patients were treated as per the PICU protocol. The PCT assay 
was done by immunoluminometric assay (BRAHMS PCT LIA; 
Neuendorfstr) and was interpreted as follows: levels <0.5 ng/ml 
indicating probable local infection and not sepsis, levels >0.5 
and <2 ng/ml as possible systemic infection, >2 and <10 ng/ml 
as likely systemic infection, and >10 ng/ml as high likelihood 
of severe sepsis or septic shock [7]. Outcome parameters were 
the length of stay in PICU and mortality.
Descriptive statistical analysis was carried out, and 
significance was assessed at 5% level of significance. Student’s 
t-test (two-tailed, independent) was used to find the significance 
of study parameters on a continuous scale between two groups-
intergroup analysis. Chi-square or Fisher exact test was used 
to find the significance of study parameters on a categorical 
scale between two or more groups, and Pearson’s coefficient 
was used to find the correlation of PCT with CRP.
RESULTS
A total of 62 patients fulfilled the inclusion criteria; of which, 
9 patients were excluded from the study due to earlier antibiotic 
use in 8 cases, and diagnosis of degenerative disease in one 
case. Of the 53 patients (54.5% males) studied, 9 (16.9%) cases 
were categorized as SIRS, 14 (26.4%) as sepsis, 8 (15.1%) as 
severe sepsis, and 22 (41.5%) as septic shock. 34 (64.2%) were 
<2 years, 10 (18.9%) aged 2-5 years, 5 (9.4%) aged 5-10 years, 
and 4 (7.5%) were more than 10 years.
The common clinical presentations were fever (96.2%), 
cough (90.6%), loose stools (26.4%), decreased activity 
and feeding (86.8%), rapid breathing (79.2%), bleeding 
manifestations (11.3%), and vomiting (7.5%). The primary 
focus of infection was the respiratory system (71.6%), followed 
by gastrointestinal and central nervous system (7.5%), and 
urinary tract infection and cellulitis (1.88%).
Out of 53 patients, 12 patients had positive blood culture 
(Staphylococcus aureus - 6, Klebsiella - 2, Escherichia 
coli - 1, Staphylococcus pneumonia - 1, Staphylococcus typhi 
- 1, Pseudomonas - 1). 7 patients (13.2%) had leukopenia, 
16 (30.2%) had normal counts, and 30 (56.6%) had leukocytosis. 
20 patients had a platelet count of <1 lakh while 33 patients had 
a platelet count of more than 1 lakh. None of the hematological 
parameters (hemoglobin, total leukocyte, and neutrophil count) 
were statistically associated with a diagnosis of sepsis or with 
PCT levels.
About 42 (79.2%) patients had values of PCT >2 ng/ml 
(p<0.05) as shown in Table 1. The mean values of serum PCT 
in the sepsis, severe sepsis, and septic shock groups were 9.63, 
17.72, and 84.68 ng/ml, respectively. Mean PCT levels were 
significantly higher in children with septic shock than in sepsis 
(p=0.013).
The mean values of serum CRP in sepsis, severe sepsis, 
and septic shock groups were 43.91, 53.75, and 90.70 mg/dl, 
respectively. We observed that the mean CRP values were 
significantly higher in more severe cases of sepsis compared 
to those with less severe illness (Table 1). The sepsis, severe 
sepsis, and septic shock groups were positively associated with 
both positive PCT and CRP. However, there was a negative 
association in SIRS group significantly with PCT (p=0.013) 
than with CRP (p=0.063), indicating that PCT is a better marker 
than CRP to differentiate SIRS from frank sepsis (Table 1).
About 11 patients (18.9%) had PCT <0.5 ng/ml and 
22 (41.55%) had PCT >10.0 ng/ml (Table 2). PCT levels of 
>10 ng/ml were present in a majority of patients in the septic 
shock and severe sepsis group. PCT positively correlated with 
CRP in around 38 (84.4%) of children with sepsis (p=0.029, 
Pearson’s correlation - 0.589). 10 (18.9%) patients died of their 
illness; of which, 7 patients (70%) had a serum PCT level of 
>10 ng/ml (Table 3). This correlation was not observed with 
CRP levels.
DISCUSSION
Sepsis has so far been diagnosed by collectively reviewing 
available parameters in the absence of a single, consistent 
laboratory marker. We have studied PCT levels in these children 
to assess its role as a single confirmatory marker of sepsis. 
There was a positive association between serum PCT levels and 
severe sepsis and septic shock and negative association with 
SIRS in this study. Sensitivity and positive predictive value 
Table 1: PCT and CRP levels
Diagnosis Number 
of patients
PCT CRP
Mean PCT values 
(ng/ml)
Positive 
n=42 (%)
Mean CRP values 
(mg/dl)
Positive 
n=46 (%)
SIRS 9 11.93 4 (44.4) 23.22 6 (66.7)
Sepsis 14 9.63 13 (92.9) 43.91 14 (100)
Severe sepsis 8 17.72 8 (100.0) 53.75 8 (100)
Septic shock 22 84.68 17 (77.3) 90.70 18 (81.8)
Total 53 p=0.013* p=0.063
PCT: Procalcitonin, SIRS: Systemic inflammatory response syndrome, CRP: C-reactive protein, *: p < 0.05
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(PPV) of PCT were high with higher PCT levels in children 
who died of their illness.
This study, therefore, confirms PCT as a useful inflammatory 
marker in pediatric sepsis. PCT is the precursor for the hormone 
calcitonin [8] found in the thyroid C-cells and the pulmonary 
endocrine cells and is greatly increased in patients with sepsis as 
a result of hypersecretion from multiple non-endocrine tissues 
throughout the body. CRP is an acute-phase reactant produced 
by hepatocytes, triggered by cytokines (IL-1, IL-6, and 
TNF-α) and its levels increase within 4-6 h of an inflammatory 
stimulus. Elevations in PCT are generally observed before 
CRP rises and levels peak within a much shorter time frame. 
In addition, when the patient responds appropriately to therapy, 
PCT levels return to normal much quicker than those of CRP. 
The mean PCT values in the study were found to be elevated 
in septic shock and severe sepsis compared to SIRS and sepsis. 
Similar findings were seen in previous studies done by Villon 
and colleagues [9], and they found that the best markers were 
serum levels of PCT for the diagnosis of spontaneous bacterial 
peritonitis at a cut-off value of 0.75 ng/ml with sensitivity of 
95% and specificity of 98%.
Fioretto et al., [10] in their study demonstrated that PCT 
measurement (p<0.05) could determine the severity of sepsis at 
the time of admission and differentiate children with sepsis from 
those with septic shock. PCT measurement also appears to be 
more useful in discriminating between sepsis and severe sepsis, 
in contrast to CRP, blood cell counts or body temperature [11]. 
In this study, the majority of the patients with septic shock and 
severe sepsis had PCT levels of >10 ng/ml. The cutoff value of 
0.5 ng/ml offered high sensitivity and good PPV in this cohort. 
Values of 0.5 - 1 ng/ml have shown to be significant in various 
studies [1,12,13].
The serum values of PCT correlate with the severity of 
sepsis which decrease with improvement and worsen with 
exacerbation of the condition. Levels between 0.5 and 2 ng/mL 
have been labeled the “gray zone” because of difficulties in 
interpreting the result. Earlier studies have failed [14] to 
establish a correlation between PCT levels and progression 
to multiorgan failure. In our study, PCT levels were higher 
in patients with severe sepsis, but daily PCT assays have not 
been done to assess the changes in the PCT values with disease 
progression.
PCT positively correlated with CRP in all groups of sepsis 
as in earlier studies [15]. However, in our study, PCT values 
correlated with a diagnosis of SIRS better than CRP. This is 
helpful to differentiate patients with SIRS from sepsis when 
signs of sepsis are misleading or absent. Casado-Flores 
et al., [16] studied 80 children with suspected sepsis and 
observed that PCT offered better diagnostic and prognostic 
correlation than CRP, and PCT levels were significantly more 
elevated among children with septic shock than in sepsis. In a 
prospective, observational study in children undergoing open 
heart surgery with cardiopulmonary bypass, PCT was able 
to differentiate between SIRS and sepsis while CRP could 
not [17]. Moreover, unlike CRP, PCT concentrations varied 
with the evolution of disease and as such could also be an 
indicator of the effectiveness of treatment [18].
In our study, neither leukocyte and platelet counts nor 
coagulation profile correlated with the severity of sepsis. 
An earlier study [19] has shown similar results, and they 
demonstrated that PCT was more useful than CRP, IL-6, and 
interferon-alpha in the early (within 12 h of illness) detection 
of invasive infection in febrile infants [20]. PCT has also been 
shown to indicate the severity of the disease and to be useful 
in differentiating bacterial from viral infections in children 
and for making decisions about antimicrobial treatment at the 
earliest [21]. Mortality was 18.9% in our study with 70% of 
the children who died having PCT levels of >10 ng/ml. This 
is similar to an earlier study which has shown that a high PCT 
level and increase in its level within a day are early independent 
predictors of mortality [22].
The limitation of our study was that the PCT levels were not 
serially monitored and not compared with a non-septic control 
group and hence, changes in the PCT level with the evolution 
of the disease and treatment could not be firmly established. 
Table 3: Correlation of PCT values with mortality
PCT Total number 
of patients (%)
SIRS (%) Sepsis (%) Septic shock 
(%)
Severe sepsis 
(%)
Mortality (%)
<0.05 10 (18.9) 5 (55.6) 1 (7.1) 4 (18.2) 0 3 (30.0)
0.05-2.0 7 (13.2) 1 (11.1) 2 (14.3) 3 (13.6) 1 (12.5) 0
2.0-10.0 14 (26.4) 2 (22.2) 7 (50.0) 5 (22.7) 0 0
>10.0 22 (41.5) 1 (11.1) 4 (28.6) 10 (45.5) 7 (87.5) 7 (70.0)
Total 53 (100.0) 9 (100.0) 14 (100.0) 22 (100.0) 8 (100.0) 10 (100.0)
PCT: Procalcitonin, SIRS: Systemic inflammatory response syndrome
Table 2: Diagnostic validity of PCT for predicting sepsis
Biomarkers Sensitivity Specificity PPV NPV Accuracy
PCT 86.36 55.56 90.48 45.45 81.13
CRP 90.91 33.33 86.96 42.86 81.13
PCT: Procalcitonin, CRP: C-reactive protein, PPV: Positive 
predictive value, NPV: Negative predictive value
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Since patients were recruited on admission to the hospital, it 
is possible that patients would be at differing phases of disease 
progression on admission, which could also influence PCT 
levels. However, we tried to minimize this effect by excluding 
children who were already on antibiotics for >48 h. There was 
a paucity of positive blood cultures, and clinical diagnostic 
criteria were used to diagnose and categorize sepsis. The PCT 
results were blinded to treating physician; treatment was not 
biased, and the outcome was not influenced by their levels.
CONCLUSION
Our study has clearly shown that PCT levels on admission could 
differentiate between sepsis and septic shock. PCT levels were 
found to be higher with increasing severity of sepsis syndromes 
and in the presence of organ dysfunction/failure, PCT levels 
also correlated with the mortality. The results suggest that PCT 
is valid for auxiliary diagnosis of sepsis in children and useful 
as an indicator of its severity.
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